Discover NashBio’s CS Oncology: a robust dataset linking registry-confirmed cancer diagnoses with over 7 years of longitudinal EHR data for clinical research.
Conventional oncology datasets miss the pre-diagnosis period. Learn how NashBio links longitudinal RWD with registry-confirmed endpoints to map the complete patient journey.
Leveraging AI framework innovations from VUMC, NashBio systematically extracts hidden statin adherence signals from unstructured clinical notes to accelerate cardiovascular research and precision medicine.
Discover how VHVI’s successful J-Valve implant and NashBio’s real-world CS Cardiology dataset are advancing structural heart treatments and life sciences R&D.
Discover how NashBio's Structured Clinical Data (SCD) and curated cancer registry data overcome ICD code limitations to enable subtype-specific oncology cohort definitions and longitudinal RWD research.
Discover how NashBio's prospective plasma collection supports Crohn's disease research with CXCL9 biomarker studies linked to longitudinal clinical phenotypes.
Echocardiogram and ECG measures sit buried in unstructured EHR reports. Learn how NashBio extracts research-ready cardiac phenotypes at scale to power cardiovascular research.
Population-scale genomics and EHR-linked biobanks are transforming cardiovascular research, enabling precision medicine, novel therapies, and deeper insights into disease subtypes.
From mortality measures to composite outcomes and surrogate biomarkers, endpoint choice shapes cardiovascular research. See how real-world data from EHRs, claims and registries strengthens it.
Vanderbilt University Medical Center (VUMC) performs a record number of solid organ transplants in 2025. Learn more about how this expertise is reflected in NashBio's data.
See how genetic research is transforming cardiovascular medicine—from identifying heritable risk factors to enabling targeted therapies for heart disease prevention.
